340 related articles for article (PubMed ID: 15067695)
1. Bidirectional transport of rhodamine 123 and Hoechst 33342, fluorescence probes of the binding sites on P-glycoprotein, across MDCK-MDR1 cell monolayers.
Tang F; Ouyang H; Yang JZ; Borchardt RT
J Pharm Sci; 2004 May; 93(5):1185-94. PubMed ID: 15067695
[TBL] [Abstract][Full Text] [Related]
2. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity.
Taub ME; Podila L; Ely D; Almeida I
Drug Metab Dispos; 2005 Nov; 33(11):1679-87. PubMed ID: 16093365
[TBL] [Abstract][Full Text] [Related]
3. The mechanism of ATP-dependent multidrug transport by P-glycoprotein.
Shapiro AB; Ling V
Acta Physiol Scand Suppl; 1998 Aug; 643():227-34. PubMed ID: 9789565
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the IPEC-J2 MDR1 (iP-gp) cell line as a tool for identification of P-gp substrates.
Ozgür B; Saaby L; Langthaler K; Brodin B
Eur J Pharm Sci; 2018 Jan; 112():112-121. PubMed ID: 29146563
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of the coumarinic acid-based cyclic prodrug of the opioid peptide DADLE.
Tang F; Borchardt RT
Pharm Res; 2002 Jun; 19(6):787-93. PubMed ID: 12134948
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of an acyloxyalkoxy-based cyclic prodrug of the opioid peptide DADLE.
Tang F; Borchardt RT
Pharm Res; 2002 Jun; 19(6):780-6. PubMed ID: 12134947
[TBL] [Abstract][Full Text] [Related]
7. Vectorial transport of the plant alkaloid berberine by double-transfected cells expressing the human organic cation transporter 1 (OCT1, SLC22A1) and the efflux pump MDR1 P-glycoprotein (ABCB1).
Nies AT; Herrmann E; Brom M; Keppler D
Naunyn Schmiedebergs Arch Pharmacol; 2008 Feb; 376(6):449-61. PubMed ID: 18157518
[TBL] [Abstract][Full Text] [Related]
8. Expression and functional activity of P-glycoprotein in passaged primary human nasal epithelial cell monolayers cultured by the air-liquid interface method for nasal drug transport study.
Cho HJ; Choi MK; Lin H; Kim JS; Chung SJ; Shim CK; Kim DD
J Pharm Pharmacol; 2011 Mar; 63(3):385-91. PubMed ID: 21749386
[TBL] [Abstract][Full Text] [Related]
9. In vitro characterization of ABC transporters involved in the absorption and distribution of liensinine and its analogs.
Yu L; Shen Q; Zhou Q; Jiang H; Bi H; Huang M; Zhou H; Zeng S
J Ethnopharmacol; 2013 Nov; 150(2):485-91. PubMed ID: 24036064
[TBL] [Abstract][Full Text] [Related]
10. Functional characterization of peptide transporters in MDCKII-MDR1 cell line as a model for oral absorption studies.
Agarwal S; Jain R; Pal D; Mitra AK
Int J Pharm; 2007 Mar; 332(1-2):147-52. PubMed ID: 17097248
[TBL] [Abstract][Full Text] [Related]
11. Efflux ratio cannot assess P-glycoprotein-mediated attenuation of absorptive transport: asymmetric effect of P-glycoprotein on absorptive and secretory transport across Caco-2 cell monolayers.
Troutman MD; Thakker DR
Pharm Res; 2003 Aug; 20(8):1200-9. PubMed ID: 12948018
[TBL] [Abstract][Full Text] [Related]
12. Comparison of bidirectional lamivudine and zidovudine transport using MDCK, MDCK-MDR1, and Caco-2 cell monolayers.
de Souza J; Benet LZ; Huang Y; Storpirtis S
J Pharm Sci; 2009 Nov; 98(11):4413-9. PubMed ID: 19472342
[TBL] [Abstract][Full Text] [Related]
13. Characterization of dexloxiglumide in vitro biopharmaceutical properties and active transport.
Tolle-Sander S; Grill A; Joshi H; Kapil R; Persiani S; Polli JE
J Pharm Sci; 2003 Oct; 92(10):1968-80. PubMed ID: 14502537
[TBL] [Abstract][Full Text] [Related]
14. Are MDCK cells transfected with the human MDR1 gene a good model of the human intestinal mucosa?
Tang F; Horie K; Borchardt RT
Pharm Res; 2002 Jun; 19(6):765-72. PubMed ID: 12134945
[TBL] [Abstract][Full Text] [Related]
15. Effect of the modulation of the membrane lipid composition on the localization and function of P-glycoprotein in MDR1-MDCK cells.
Kamau SW; Krämer SD; Günthert M; Wunderli-Allenspach H
In Vitro Cell Dev Biol Anim; 2005; 41(7):207-16. PubMed ID: 16223335
[TBL] [Abstract][Full Text] [Related]
16. Characterization of P-glycoprotein mediated transport of K02, a novel vinylsulfone peptidomimetic cysteine protease inhibitor, across MDR1-MDCK and Caco-2 cell monolayers.
Zhang Y; Benet LZ
Pharm Res; 1998 Oct; 15(10):1520-4. PubMed ID: 9794492
[TBL] [Abstract][Full Text] [Related]
17. Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors.
Profit L; Eagling VA; Back DJ
AIDS; 1999 Sep; 13(13):1623-7. PubMed ID: 10509562
[TBL] [Abstract][Full Text] [Related]
18. Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities.
Shapiro AB; Ling V
Eur J Biochem; 1997 Nov; 250(1):130-7. PubMed ID: 9432000
[TBL] [Abstract][Full Text] [Related]
19. Avermectin transepithelial transport in MDR1- and MRP-transfected canine kidney monolayers.
Brayden DJ; Griffin J
Vet Res Commun; 2008 Jan; 32(1):93-106. PubMed ID: 17578674
[TBL] [Abstract][Full Text] [Related]
20. Rhodamine 123 requires carrier-mediated influx for its activity as a P-glycoprotein substrate in Caco-2 cells.
Troutman MD; Thakker DR
Pharm Res; 2003 Aug; 20(8):1192-9. PubMed ID: 12948017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
